S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
BioPlus Acquisition Corporation (BIOS)
BioPlus Acquisition Corporation (BIOS) News

BIOS

BioPlus Acquisition (BIOS)

BioPlus Acquisition Corporation

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:BIOS

1 2 3 4 5 6 7 8 9 10 Next >>

Date	Time	Source	Headline	Symbol	Company
10/04/2023	6:30AM	GlobeNewswire Inc.	BioPlus Acquisition Corp. Announces Termination of Business Combination Agreement with Avertix Medical, Inc. and its Intention to Liquidate	NASDAQ:BIOS	BioPlus Acquisition Corporation
10/04/2023	6:30AM	GlobeNewswire Inc.	Avertix and BIOS Acquisition Corporation Mutually Agree to Terminate Proposed Business Combination	NASDAQ:BIOS	BioPlus Acquisition Corporation
08/16/2023	7:30AM	GlobeNewswire Inc.	Heart & Rhythm Institute of Trinity and Avertix Announce Partnership to Improve Cardiac Care and Patient Monitoring	NASDAQ:BIOS	BioPlus Acquisition Corporation
07/17/2023	7:00AM	GlobeNewswire Inc.	Renown Cardiologist and Professor Ian T. Meredith, MD to Join Avertix Medical’s Board of Directors	NASDAQ:BIOS	BioPlus Acquisition Corporation
06/14/2023	5:09AM	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:BIOS	BioPlus Acquisition Corporation
06/14/2023	5:06AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:BIOS	BioPlus Acquisition Corporation
06/13/2023	7:30AM	GlobeNewswire Inc.	Avertix’s Guardian™ System, First and Only FDA-Approved Implantable Heart Attack Detection and Warning System, Now Available at AdventHealth Orlando	NASDAQ:BIOS	BioPlus Acquisition Corporation
05/30/2023	3:04PM	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:BIOS	BioPlus Acquisition Corporation
05/19/2023	3:50PM	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:BIOS	BioPlus Acquisition Corporation
05/19/2023	3:05PM	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:BIOS	BioPlus Acquisition Corporation
05/15/2023	3:29PM	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:BIOS	BioPlus Acquisition Corporation
05/15/2023	5:38AM	Edgar (US Regulatory)	Securities Registration: Business Combination (s-4)	NASDAQ:BIOS	BioPlus Acquisition Corporation
05/12/2023	3:17PM	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:BIOS	BioPlus Acquisition Corporation
05/03/2023	7:47AM	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:BIOS	BioPlus Acquisition Corporation
05/03/2023	7:44AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:BIOS	BioPlus Acquisition Corporation
05/03/2023	7:30AM	GlobeNewswire Inc.	Avertix, Maker of First and Only FDA-Approved Implantable Heart Attack Warning System, to Become Publicly Traded via Merger with BIOS Acquisition Corporation	NASDAQ:BIOS	BioPlus Acquisition Corporation
04/27/2023	3:35PM	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NASDAQ:BIOS	BioPlus Acquisition Corporation
02/14/2023	2:39PM	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:BIOS	BioPlus Acquisition Corporation
02/02/2023	9:10AM	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:BIOS	BioPlus Acquisition Corporation
11/03/2022	4:10PM	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:BIOS	BioPlus Acquisition Corporation
10/11/2022	3:07PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:BIOS	BioPlus Acquisition Corporation
08/10/2022	3:33PM	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:BIOS	BioPlus Acquisition Corporation
05/12/2022	3:55PM	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:BIOS	BioPlus Acquisition Corporation
03/11/2022	3:05PM	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:BIOS	BioPlus Acquisition Corporation
02/09/2022	1:14PM	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:BIOS	BioPlus Acquisition Corporation
12/06/2021	7:00AM	GlobeNewswire Inc.	BioPlus Acquisition Corp. Announces Pricing of Upsized $200,000,000 Initial Public Offering	NASDAQ:BIOS	BioPlus Acquisition Corporation
12/02/2021	7:55PM	GlobeNewswire Inc.	BioPlus Acquisition Corp. Announces Pricing of Upsized $200,000,000 Initial Public Offering	NASDAQ:BIOS	BioPlus Acquisition Corporation
02/03/2020	7:30AM	GlobeNewswire Inc.	Option Care Health Completes Reverse Stock Split and Ticker Symbol Change	NASDAQ:BIOS	BioPlus Acquisition Corporation
12/26/2019	3:24PM	GlobeNewswire Inc.	RLH Corporation Appoints R. Carter Pate as Chairman	NASDAQ:BIOS	BioPlus Acquisition Corporation
12/18/2019	8:22AM	GlobeNewswire Inc.	Option Care Health to Participate in the 38th Annual J.P. Morgan Healthcare Conference	NASDAQ:BIOS	BioPlus Acquisition Corporation

Showing the most relevant articles for your search:NASDAQ:BIOS

1 2 3 4 5 6 7 8 9 10 Next >>

ProText Mobility (PK)

TransCode Therapeutics

Emergent Health (PK)

Music Licensing (PK)

Nexus Energy Services (PK)

Net Savings Link (PK)

Yuenglings Ice Cream (PK)

Globestar Therapeutics (PK)

TideRock Companies (PK)

Cann American (CE)

Innovation Pharmaceuticals (CE)

Decentral Life (PK)

Elite Pharmaceuticals (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions